Results 21 to 30 of about 87,373,768 (197)
Frontiers in Psychiatry, 2023 Stigma toward people taking medication for opioid use disorder (MOUD) is prevalent, harmful to the health and well-being of this population, and impedes MOUD treatment resource provision, help-seeking, and engagement in care.
Timothy D. Becker +5 more
doaj +1 more source
Discordance in Addressing Opioid Crisis in Rural Communities: Patient and Provider Perspectives
Pharmacy, 2022 Providing patient-centered care to manage chronic pain and opioid use disorder (OUD) is associated with improved health outcomes. However, adopting a holistic approach to providing care is often challenging in rural communities.
Bonyan Qudah +3 more
doaj +1 more source
Annals of Medicine, 2023 Introduction Treatment for opioid use disorder (OUD) with diacetylmorphine is an evidence-based form of drug treatment, but it is not available in the United States (US).
Sean T. Allen +6 more
doaj +1 more source
A Systematic Review Examining Patient and Provider Attitudes Toward Use of Medication for Opioid Use Disorder [paper] [PDF]
, 2023 School of Nursing CapstonesIntroduction: Despite drastically rising rates of opioid overdose related deaths, rigid opinions of both patients and providers against the use of medication for opioid use disorder persist in the face of well-established ...
Trejo, Anyssa
core +1 more source
Medication-Assisted Treatment for Opioid-Use Disorder [PDF]
Mayo Clinic Proceedings, 2019 The United States is in the midst of a national opioid epidemic. Physicians are encouraged both to prevent and treat opioid-use disorders (OUDs). Although there are 3 Food and Drug Administration-approved medications to treat OUD (methadone, buprenorphine, and naltrexone) and there is ample evidence of their efficacy, they are not used as often as they
Tyler S. Oesterle +3 more
openaire +2 more sources
Methamphetamine use and utilization of medications for opioid use disorder among rural people who use drugs [PDF]
, 2023 Background: Methamphetamine use is common among persons with opioid use disorder. This study evaluated associations between methamphetamine use and treatment with agonist medications for opioid use disorder (MOUD, specifically buprenorphine, and/or ...
Friedmann, Peter, MD
core +2 more sources
Medications for management of opioid use disorder
American Journal of Health-System Pharmacy, 2019 Abstract Purpose The use of buprenorphine, methadone, and long-acting naltrexone for treatment of opioid use disorder (OUD) is discussed, including a review of current literature detailing treatment approaches and action steps to optimize treatment in acute care and office-based settings.
Jennifer L, Koehl +2 more
openaire +2 more sources
Addiction Science & Clinical Practice, 2022 Background Morbidity and mortality related to opioid use disorder (OUD) in the U.S. is at an all-time high. Innovative approaches are needed to address gaps in retention in treatment with medications for opioid use disorder (MOUD). Mobile health (mHealth)
Jacqueline Hodges +11 more
doaj +1 more source
Development and implementation of a physician-pharmacist collaborative practice model for provision and management of buprenorphine/naloxone [PDF]
Mental Health Clinician, 2021 Introduction: Physician-pharmacist collaborative practice models (PPCPM) decrease barriers and increase access to medications for opioid use disorder (MOUD) but are not routine in practice. The purpose of this quality improvement initiative is to develop
Lindsay M. Mailloux, PharmD +3 more
doaj +1 more source
JAMA Network Open, 2023 This cross-sectional study uses data from the 2021 National Survey on Drug Use and Health to estimate the receipt of medication for opioid use disorder among US adults with past-year opioid use disorder.
Jones, Christopher M. +4 more
openaire +2 more sources